Seite drucken Druckansicht schließen
Logo Going International
Neue Suche | Kongressdetail
 

2nd Annual RNAi-Based Therapeutics Summit - June 2021 - Digital Event

Evvnt Promotion / evvnt
Archiv
-
15.06.2021 - 17.06.2021  Virtual
Time: 9:00 am - 5:00 pm
 
Kongressthemen
As investments and collaborations hit a record high, the RNAi therapeutics industry continues to rapidly expand. With RNAi drugs prevailing as a therapy with huge potential against liver diseases, exciting efforts have now turned to a wide range of other diseases, from CNS, oncology, metabolism and more. Despite the growing momentum, much needs to be addressed in terms of targeted delivery, safety, and efficiency to fully unleash the therapeutic value of RNAi drugs.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Speakers: Greg Hinkle Vice President, Research Informatics Alnylam Pharmaceuticals, Ekkehard Leberer Senior Director, R&D Alliance Management Sanofi, Julia Alterman Senior Scientist Khvorova Lab University of Massachusetts Medical School and more
 

Anfragen und Anmeldung:

https://go.evvnt.com/733422-0?pid=4832
Herr Customer Service
 
Kategorien
Allgemeinmedizin, Public Health
Sprache
Englisch
Kongressgebühr
Conference Only: USD 1999.00, Conference + 1 Workshop: USD 2348.00, Conference + 2 Workshops: USD 2697.00
Teilnehmer erwartet
1000
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien